Home >> Industry News >> Siemens offers NT‑proBNPII assay on Atellica Solution

Siemens offers NT‑proBNPII assay on Atellica Solution

image_pdfCreate PDF

June 28, 2024—Siemens Healthineers has added the NT‑proBNPII assay to its cardiac test menu on the Atellica Solution to help diagnose heart failure. The assay supports timely patient care with a first result available in 10 minutes. The company offers the NT-proBNPII and B-type natriuretic peptide tests on either the Atellica IM or Atellica CI analyzer.

CAP TODAY
X